133 related articles for article (PubMed ID: 32915437)
21. Stage migration with the new American Joint Committee on Cancer (AJCC) staging system (8th edition) for differentiated thyroid cancer.
Shaha AR; Migliacci JC; Nixon IJ; Wang LY; Wong RJ; Morris LGT; Patel SG; Shah JP; Tuttle RM; Ganly I
Surgery; 2019 Jan; 165(1):6-11. PubMed ID: 30415873
[TBL] [Abstract][Full Text] [Related]
22. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
23. Reassessment of Differentiated Thyroid Cancer Patients Using the Eighth TNM/AJCC Classification System: A Comparative Study.
Shteinshnaider M; Muallem Kalmovich L; Koren S; Or K; Cantrell D; Benbassat C
Thyroid; 2018 Feb; 28(2):201-209. PubMed ID: 29256827
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of the AJCC 8th edition staging system for Japanese patients treated with surgery followed by radiotherapy for breast cancer.
Tang L; Ishikawa Y; Matsushita H; Jingu K
Int J Clin Oncol; 2020 Aug; 25(8):1499-1505. PubMed ID: 32356049
[TBL] [Abstract][Full Text] [Related]
25. Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma.
Mazloumi M; Vichitvejpaisal P; Dalvin LA; Yaghy A; Ewens KG; Ganguly A; Shields CL
JAMA Ophthalmol; 2020 Mar; 138(3):260-267. PubMed ID: 31944225
[TBL] [Abstract][Full Text] [Related]
26. Outcome prediction with the revised American joint committee on cancer staging system and American thyroid association guidelines for thyroid cancer.
Suh S; Kim YH; Goh TS; Lee J; Jeong DC; Oh SO; Hong JC; Kim SJ; Kim IJ; Pak K
Endocrine; 2017 Dec; 58(3):495-502. PubMed ID: 29030773
[TBL] [Abstract][Full Text] [Related]
27. Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer.
Trybek T; Walczyk A; Gąsior-Perczak D; Pałyga I; Mikina E; Kowalik A; Hińcza K; Kopczyński J; Chrapek M; Góźdź S; Kowalska A
Endocrinology; 2019 Oct; 160(10):2328-2338. PubMed ID: 31305897
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Utility of Tumor Stage versus American Thyroid Association Risk Class in Thyroid Cancer.
Abiri A; Pang J; Prasad KR; Goshtasbi K; Kuan EC; Armstrong WB; Haidar YM; Tjoa T
Laryngoscope; 2023 Jan; 133(1):205-211. PubMed ID: 35716358
[TBL] [Abstract][Full Text] [Related]
29. An Analysis of The American Joint Committee on Cancer 8th Edition T Staging System for Papillary Thyroid Carcinoma.
Tran B; Roshan D; Abraham E; Wang L; Garibotto N; Wykes J; Campbell P; Ebrahimi A
J Clin Endocrinol Metab; 2018 Jun; 103(6):2199-2206. PubMed ID: 29672723
[TBL] [Abstract][Full Text] [Related]
30. Modification of the 8th American Joint Committee on Cancer staging system for gallbladder carcinoma to improve prognostic precision.
Jiang W; Zhao B; Li Y; Qi D; Wang D
BMC Cancer; 2020 Nov; 20(1):1129. PubMed ID: 33225924
[TBL] [Abstract][Full Text] [Related]
31.
Park J; Lee S; Kim K; Park H; Ki CS; Oh YL; Shin JH; Kim JS; Kim SW; Chung JH; Kim TH
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562809
[TBL] [Abstract][Full Text] [Related]
32. The Prognostic Value of the AJCC 8th Edition Staging System for Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer.
Kantor O; Bao J; Jaskowiak N; Yao K; Tseng J
Ann Surg Oncol; 2020 Feb; 27(2):352-358. PubMed ID: 31376037
[TBL] [Abstract][Full Text] [Related]
33. DOES T STAGE AFFECT PROGNOSIS IN PATIENTS WITH STAGE IV B DIFFERENTIATED THYROID CANCER?
Li M; Trivedi N; Dai C; Mao R; Wang Y; Ning Y; Gu SZ; Huo L; Siddiqui AD
Endocr Pract; 2019 Sep; 25(9):877-886. PubMed ID: 31170365
[No Abstract] [Full Text] [Related]
34. Staging HPV-related oropharyngeal cancer: Validation of AJCC-8 in a surgical cohort.
Geltzeiler M; Bertolet M; Albergotti W; Gleysteen J; Olson B; Persky M; Gross N; Li R; Andersen P; Kim S; Ferris RL; Duvvuri U; Clayburgh D
Oral Oncol; 2018 Sep; 84():82-87. PubMed ID: 30115481
[TBL] [Abstract][Full Text] [Related]
35. TNM 8th edition in thyroid cancer staging: is there an improvement in predicting recurrence?
Manzardo OA; Cellini M; Indirli R; Dolci A; Colombo P; Carrone F; Lavezzi E; Mantovani G; Mazziotti G; Arosio M; Lania AGA
Endocr Relat Cancer; 2020 Jun; 27(6):325-336. PubMed ID: 32229701
[TBL] [Abstract][Full Text] [Related]
36. Clinical Value of Lymph Node Ratio Integration with the 8
Lee J; Lee SG; Kim K; Yim SH; Ryu H; Lee CR; Kang SW; Jeong JJ; Nam KH; Chung WY; Jo YS
Sci Rep; 2019 Sep; 9(1):13361. PubMed ID: 31527831
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive transcriptomic analysis of papillary thyroid cancer: potential biomarkers associated with tumor progression.
Hosseinkhan N; Honardoost M; Blighe K; Moore CBT; Khamseh ME
J Endocrinol Invest; 2020 Jul; 43(7):911-923. PubMed ID: 31965517
[TBL] [Abstract][Full Text] [Related]
38. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma.
Abdel-Rahman O
Lung Cancer; 2017 Nov; 113():128-133. PubMed ID: 29110839
[TBL] [Abstract][Full Text] [Related]
39. Is a simplified TNM staging system more clinically relevant than the American Joint Committee on Cancer system for the follicular variant of papillary thyroid cancer?
Hu D; Huang Y; Zeng W; Chen S; Huang Y; Li M; Long W; Huang J; Wei W; Zhang C; Liu Z; Guo L
Ann Transl Med; 2020 Apr; 8(7):463. PubMed ID: 32395507
[TBL] [Abstract][Full Text] [Related]
40. Benefits of the 8th American Joint Committee on Cancer System for Hepatocellular Carcinoma Staging.
Satala CB; Jung I; Kobori L; Kovacs Z; Fodor D; Szodorai R; Gurzu S
J Gastrointest Cancer; 2021 Mar; 52(1):243-248. PubMed ID: 32173767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
